| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ART.24836 |
| P698 | PubMed publication ID | 19877093 |
| P50 | author | Marjolein Visser | Q39951790 |
| Coenraad Dirk Adriaan Stehouwer | Q68596151 | ||
| P2093 | author name string | Giel Nijpels | |
| Jacqueline M Dekker | |||
| Michael T Nurmohamed | |||
| Maarten Boers | |||
| Yvo M Smulders | |||
| Ben A C Dijkmans | |||
| Alexandre E Voskuyl | |||
| Willem F Lems | |||
| Mike J L Peters | |||
| Rob Heine | |||
| Vokko P van Halm | |||
| P433 | issue | 11 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 1571-1579 | |
| P577 | publication date | 2009-11-01 | |
| P1433 | published in | Arthritis and Rheumatism | Q23929027 |
| P1476 | title | Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study | |
| P478 | volume | 61 |
| Q36193944 | Abatacept improves whole-body insulin sensitivity in rheumatoid arthritis: an observational study. |
| Q60935904 | Acupuncture decreased the risk of coronary heart disease in patients with rheumatoid arthritis in Taiwan: a Nationwide propensity score-matched study |
| Q90747262 | Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities |
| Q35102474 | Advances in the medical treatment of rheumatoid arthritis |
| Q34274205 | An evaluation of rheumatology practitioner outreach clinics: a qualitative study |
| Q90076899 | Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial |
| Q36797524 | Aortic VCAM-1: an early marker of vascular inflammation in collagen-induced arthritis |
| Q36193742 | Association of the Charlson comorbidity index with renal outcome and all-cause mortality in antineutrophil cytoplasmatic antibody-associated vasculitis |
| Q38365624 | Atherosclerotic vascular disease in the autoimmune rheumatologic patient |
| Q92104941 | Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis |
| Q36154527 | Body composition in patients with rheumatoid arthritis is not different than healthy subjects |
| Q27008927 | Cardiorheumatology: cardiac involvement in systemic rheumatic disease |
| Q54255528 | Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients. |
| Q88917533 | Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis |
| Q33713206 | Cardiovascular case fatality in rheumatoid arthritis is decreasing; first prospective analysis of a current low disease activity rheumatoid arthritis cohort and review of the literature |
| Q35557796 | Cardiovascular co-morbidity in patients with rheumatic diseases. |
| Q92464675 | Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment |
| Q26823443 | Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure |
| Q33943374 | Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment |
| Q34385631 | Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care |
| Q35617716 | Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study |
| Q37808570 | Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications |
| Q26744334 | Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps |
| Q34563216 | Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment |
| Q35496549 | Cardiovascular risk management in patients with active ankylosing spondylitis: a detailed evaluation |
| Q34167653 | Cardiovascular risk management in patients with inflammatory arthritis: what is good for the joint is good for the heart and vice versa! |
| Q37055056 | Cardiovascular risk score in Rheumatoid Arthritis |
| Q35012458 | Cardiovascular screening in rheumatoid arthritis: a cross-sectional primary care database study |
| Q92184778 | Changes in Lipid Levels and Incidence of Cardiovascular Events Following Tofacitinib Treatment in Patients With Psoriatic Arthritis: A Pooled Analysis Across Phase III and Long-Term Extension Studies |
| Q37691111 | Classical cardiovascular disease risk factors associate with vascular function and morphology in rheumatoid arthritis: a six-year prospective study. |
| Q38615462 | Co-morbidity index in rheumatoid arthritis: time to think |
| Q42680293 | Comorbidities and health-related quality of life in Koreans with knee osteoarthritis: Data from the Korean National Health and Nutrition Examination Survey (KNHANES). |
| Q33579891 | Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey |
| Q49788530 | Comparative Cardiovascular Risk of Abatacept and Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis With and Without Diabetes Mellitus: A Multidatabase Cohort Study |
| Q36220832 | Comparisons between comorbid conditions and health care consumption in rheumatoid arthritis patients with or without biological disease-modifying anti-rheumatic drugs: a register-based study. |
| Q41901454 | Confounding by indication probably distorts the relationship between steroid use and cardiovascular disease in rheumatoid arthritis: results from a prospective cohort study |
| Q36253978 | Contractile, but not endothelial, dysfunction in early inflammatory arthritis: a possible role for matrix metalloproteinase-9 |
| Q92733573 | Could Omega 3 Fatty Acids Preserve Muscle Health in Rheumatoid Arthritis? |
| Q37814078 | Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis |
| Q39283765 | Diabetes mellitus and arthritis: is it a risk factor or comorbidity?: A systematic review and meta-analysis |
| Q82601402 | Effect of xinfeng capsule on the cardiac function in patients with rheumatoid arthritis |
| Q90096848 | Effects of Colchicine on Atherosclerotic Plaque Stabilization: a Multimodality Imaging Study in an Animal Model |
| Q50085156 | Endothelium-derived contraction in a model of rheumatoid arthritis is mediated via angiotensin II type 1 receptors |
| Q37883018 | Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. |
| Q31136476 | Evaluation of Audiometric Test Results to Determine Hearing Impairment in Patients with Rheumatoid Arthritis: Analysis of Data from the Korean National Health and Nutrition Examination Survey |
| Q41581710 | Features of cardiac remodeling in Patients with Acute Coronary Syndrome Complicated with Rheumatoid Arthritis. |
| Q37672346 | Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis |
| Q50069479 | Hypermetabolic macrophages in rheumatoid arthritis and coronary artery disease due to glycogen synthase kinase 3b inactivation. |
| Q64911996 | Illuminating an Invisible Epidemic: A Systemic Review of the Clinical and Economic Benefits of Early Diagnosis and Treatment in Inflammatory Disease and Related Syndromes. |
| Q33678290 | Imaging atherosclerosis in rheumatoid arthritis: evidence for increased prevalence, altered phenotype and a link between systemic and localised plaque inflammation. |
| Q39037766 | Impact of body weight on the achievement of minimal disease activity in patients with rheumatic diseases: a systematic review and meta-analysis |
| Q49911536 | Incident Heart Failure in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study |
| Q92256742 | Inflammation as a Therapeutic Target in Atherosclerosis |
| Q51152425 | Inflammation-related cardiovascular morbidity : Pathophysiology and therapy |
| Q35152141 | Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis |
| Q57071972 | Intervention of integrative medicine treatment has impact on serum levels of ET-1, TNF-α, MLT in RA-CVD |
| Q33847043 | Left ventricular function in treatment-naive early rheumatoid arthritis |
| Q55242105 | Lipid management among individuals with inflammatory arthritis in the national REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort. |
| Q64945484 | Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn's disease: a pooled analysis of 11 317 patients across clinical trials. |
| Q36182351 | Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis |
| Q37058791 | Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion |
| Q27694518 | Managing cardiovascular risk in patients with inflammatory arthritis: practical considerations |
| Q38181283 | Mechanisms of endothelial dysfunction in rheumatoid arthritis: lessons from animal studies |
| Q47929039 | Metabolic abnormalities in rheumatoid arthritis patients with comorbid diabetes mellitus. |
| Q33695937 | Myocardial Perfusion in Rheumatoid Arthritis Patients: Associations with Traditional Risk Factors and Novel Biomarkers |
| Q38076350 | Novel mechanisms of action of the biologicals in rheumatic diseases. |
| Q34128912 | Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis |
| Q60952997 | Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis in a geographically distant National Register-based cohort: an external validation |
| Q36235589 | Perioperative all-cause mortality and cardiovascular events in patients with rheumatoid arthritis: comparison with unaffected controls and persons with diabetes mellitus |
| Q64093765 | Plasma from Patients with Rheumatoid Arthritis Reduces Nitric Oxide Synthesis and Induces Reactive Oxygen Species in A Cell-Based Biosensor |
| Q35827321 | Prevalence of Cognitive Impairment in Recently Diagnosed Type 2 Diabetes Patients: Are Chronic Inflammatory Diseases Responsible for Cognitive Decline? |
| Q52562359 | Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study. |
| Q59793023 | Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study |
| Q38612651 | Prevention of Stroke in Rheumatoid Arthritis |
| Q53502883 | Prevention of stroke in rheumatoid arthritis. |
| Q89121860 | Recognition and control of hypertension, diabetes, and dyslipidemia in patients with rheumatoid arthritis |
| Q36054251 | Rheumatoid Arthritis Disadvantages Younger Patients for Cardiovascular Diseases: A Meta-Analysis. |
| Q35957651 | Rheumatoid Arthritis and Incidence of Twelve Initial Presentations of Cardiovascular Disease: A Population Record-Linkage Cohort Study in England |
| Q92051641 | Rheumatoid Arthritis and Vascular Failure - Rheumatoid Arthritis Is a Risk Factor for Cardiovascular Disease |
| Q99581776 | Rheumatoid Arthritis is Not Associated with Increased Inpatient Mortality in Patients Admitted for Acute Coronary Syndrome |
| Q36001551 | Rheumatoid Arthritis, Anti-Cyclic Citrullinated Peptide Positivity, and Cardiovascular Disease Risk in the Women's Health Initiative |
| Q38149252 | Rheumatoid arthritis and cardiovascular disease |
| Q37691220 | Rheumatoid arthritis is associated with reduced adiposity but not with unfavorable major cardiovascular risk factor profiles and enhanced carotid atherosclerosis in black Africans from a developing population: a cross-sectional study |
| Q37104380 | Risk for cardiovascular disease in Japanese patients with rheumatoid arthritis: a large-scale epidemiological study using a healthcare database |
| Q37294162 | Serum Resistin Level and Progression of Atherosclerosis during Glucocorticoid Therapy for Systemic Autoimmune Diseases |
| Q99402999 | Serum chemerin in patients with rheumatoid arthritis: can it unravel the Chimera of concomitant type 2 diabetes? |
| Q36907729 | Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort analysis |
| Q89314644 | Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases |
| Q37894193 | TNF alpha antagonist therapy and safety monitoring |
| Q26828369 | Targeting B cells in atherosclerosis: closing the gap from bench to bedside |
| Q35336802 | The 'Switch' study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug |
| Q59795584 | The effects of golimumab treatment on systolic and diastolic left ventricular function in ankylosing spondylitis |
| Q35387131 | The increased cardiovascular risk in patients affected by autoimmune diseases: review of the various manifestations |
| Q42345713 | The increased cardiovascular risk in rheumatoid arthritis: when does it start? |
| Q33892790 | The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study |
| Q41838724 | The risk of comorbidity. |
| Q36907676 | The role of inflammation, the autonomic nervous system and classical cardiovascular disease risk factors on subendocardial viability ratio in patients with RA: a cross-sectional and longitudinal study. |
| Q26765122 | The specialist physician's approach to rheumatoid arthritis in South Africa |
| Q36923331 | Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study. |
| Q26822912 | Unresolved questions in rheumatology: motion for debate: the data support evidence-based management recommendations for cardiovascular disease in rheumatoid arthritis |
| Q38221011 | Use of DXA-based technology for detection and assessment of risk of vertebral fracture in rheumatology practice |
| Q34164481 | Validated methods for assessment of subclinical atherosclerosis in rheumatology |
| Q37720349 | Whole body bone tissue and cardiovascular risk in rheumatoid arthritis |
Search more.